2Travadi JN,Patole SK.Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn:A review.Pediatric Pulmonology,2003,36:529-535.
3Endo A,Ayusawa M,Minato M,et al.Endogenous nitric oxide and ET-1 in persistent pulmonary hypertension of the newborn.Eur J Pediatr,2001,160:217-222.
4Truog WE,Pallotto E,Clark P,et al.Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants.Clin Sci (Lond),2002,103:294S-297S.
5Yanagisawa M,Kurihara H,Kimura S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature,1988,332:411-415.
7Wieoke JL,Montrese-Rafizaden C,Zeithin PL,et al.Effect of hypoxia on endothelin-1 production by pulmonary vascular endothelial cells.Biochim Biophys Acta,1992,1134:105-111.
8Mattoli S,Mezzetti M,Riva G.Specific binding of endothelin on human bronchial smooth muscle cells in culcure and section of endothelin-like material from bronchial.Am J Respir Cell Mol Biol,1990,3:145-151.
9Rozengurt N,Springall DR,Polak JM.Localizatio of endothelin-like immunoreactivity in airway epithelium of rats and mice.J Pathol,1990,16:5-13.
10Battistini B,Forget MA,Laisht D.Petential rotes for endothelin in systenic inflammatory response syndrome with a particular relationship to cytokines.Shoke,1996,5:167-171.
